))
Integra LifeSciences to buy J&J's Acclarent; Ashley McEvoy takes board role at consumer goods giant
Manage episode 389402849 series 3481361
Content provided by Fast Five by MassDevice. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Fast Five by MassDevice or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, December 14, 2023. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. Ekso Bionics announced it earned a Medicare win for its exoskeleton technology this week. Fast Five hosts Sean Whooley and Danielle Kirsh discuss what the win means for the company and the technology it is developing. Calyxo closed a $50 million funding round to support kidney stone treatment. Hear how much funding the company has received in recent years and what the company's technology does. Tandem Diabetes Care has launched its diabetes management platform for insulin pump users. Whooley talks about what the new platform is designed for and some other positive news from the company in recent months. Former Johnson & Johnson MedTech head Ashley McEvoy has landed a board position at a consumer goods giant. Learn where she is joining the board in today's episode. Integra LifeSciences is buying J&J's Acclarent and its ENT technology. Whooley and Kirsh discuss the financial details of the deal and how it will supplement Integra LifeSciences' portfolio.
…
continue reading
161 episodes
Share
